Business Description
Astrana Health Inc
NAICS : 621999
SIC : 8099
ISIN : US03763A2078
Share Class Description:
FRA:3AM: Ordinary SharesTotal Employee Number:
3,000Description
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.41 | |||||
Equity-to-Asset | 0.36 | |||||
Debt-to-Equity | 1.18 | |||||
Debt-to-EBITDA | 5.14 | |||||
Interest Coverage | 1.49 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.84 | |||||
Beneish M-Score | -2.17 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 37 | |||||
3-Year EBITDA Growth Rate | 3.7 | |||||
3-Year EPS without NRI Growth Rate | 17.4 | |||||
3-Year FCF Growth Rate | 17.7 | |||||
3-Year Book Growth Rate | 11 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 74.08 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 14.6 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 53.69 | |||||
9-Day RSI | 51.46 | |||||
14-Day RSI | 49.29 | |||||
3-1 Month Momentum % | -3.64 | |||||
6-1 Month Momentum % | 62.24 | |||||
12-1 Month Momentum % | 59.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.23 | |||||
Quick Ratio | 1.23 | |||||
Cash Ratio | 0.54 | |||||
Days Sales Outstanding | 38.68 | |||||
Days Payable | 4.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.6 | |||||
Shareholder Yield % | -31.23 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 10.46 | |||||
Operating Margin % | 2.61 | |||||
Net Margin % | 1.06 | |||||
EBITDA Margin % | 4.95 | |||||
FCF Margin % | 2.47 | |||||
OCF Margin % | 2.82 | |||||
ROE % | 5.13 | |||||
ROA % | 1.92 | |||||
ROIC % | 3.87 | |||||
3-Year ROIIC % | -0.63 | |||||
ROC (Joel Greenblatt) % | 149.27 | |||||
ROCE % | 8.68 | |||||
Years of Profitability over Past 10-Year | 7 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 46.32 | |||||
Forward PE Ratio | 31.94 | |||||
PE Ratio without NRI | 18.06 | |||||
Shiller PE Ratio | 68.63 | |||||
Price-to-Owner-Earnings | 34.22 | |||||
PEG Ratio | 0.8 | |||||
PS Ratio | 0.49 | |||||
PB Ratio | 2.25 | |||||
Price-to-Free-Cash-Flow | 19.82 | |||||
Price-to-Operating-Cash-Flow | 17.36 | |||||
EV-to-EBIT | 17.51 | |||||
EV-to-Forward-EBIT | 9.83 | |||||
EV-to-EBITDA | 11.71 | |||||
EV-to-Forward-EBITDA | 8.2 | |||||
EV-to-Revenue | 0.58 | |||||
EV-to-Forward-Revenue | 0.67 | |||||
EV-to-FCF | 23.64 | |||||
Price-to-GF-Value | 0.59 | |||||
Price-to-Projected-FCF | 1.41 | |||||
Price-to-Median-PS-Value | 0.41 | |||||
Earnings Yield (Greenblatt) % | 5.71 | |||||
FCF Yield % | 5.01 |
Astrana Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Astrana Health Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2027-03-12 | In 179 days | ||
| Fourth quarter earnings conference call for 2026 | 2027-03-02 08:30 | In 170 days | ||
| Fourth quarter earnings results for 2026 | 2027-03-02 | In 169 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-06 17:30 | In 54 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 53 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-06 17:30 | 30.40 (-2.56%) | ||
| Second quarter earnings results for 2026 | 2026-08-06 | 30.40 (-2.56%) | ||
| General meeting for 2026 | 2026-06-10 10:00 | 32.60 (-1.21%) | ||
| 46th annual william blair growth stock conference | 2026-06-03 16:00 | 31.60 (-1.25%) | ||
| Guidance call for 2026 | 2026-05-12 18:40 | 32.60 (-1.81%) |
Show
Entries
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers